MAL2 and thymoma: For MAL2, we found that, while high gene expression is linked to shorter survival in 4 cancer types (pancreatic ductal adenocarcinoma, uveal melanoma, thymoma and uterine corpus endometrial carcinoma), it is linked to better survival in bladder urothelial and head and neck squamous cell carcinoma.